Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of 68GA DOTATATE PET/CT In Breast Cancer Imaging; a Prospective Study Compared With 18F FDG PET/CT

NCT06359054 is registered in ClinicalTrials.gov with Manisa Celal Bayar University as lead sponsor.

NCT NCT06359054
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06359054 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of 68GA DOTATATE PET/CT In Breast Cancer Imaging; a Prospective Study Compared With 18F FDG PET/CT
Lead sponsor
Manisa Celal Bayar University
Phase
Not applicable
Overall status
Completed
Start date
November 11, 2020
Completion date
September 15, 2023
Enrollment
16 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer